Back
VanEck Digital Transformation ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Sell
40
DAPP
VanEck Digital Transformation ETF
Last Price:
$16.87
Seasonality Move:
-16.4%
Buy
64
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$90.20
Seasonality Move:
-30.03%
Sell
40
VanEck Digital Transformation ETF (DAPP)
is a Sell
Is VanEck Digital Transformation ETF a Buy, Sell or Hold?
-
The current VanEck Digital Transformation ETF [DAPP] share price is $17.10. The Score for DAPP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
DAPP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $93.99. The Score for DRUG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAPP Stock Price Chart
What is VanEck Digital Transformation ETF's stock price today?
-
The VanEck Digital Transformation ETF share price today is $17.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAPP is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $93.99Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
DAPP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 38.62 | Sell |
| Chaikin Money Flow: | 3467084 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.04 - 19.64) | Sell |
| Bollinger Bands (100): | (17 - 23.18) | Sell |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.78 | Buy |
| Relative Strength Index (14 RSI): | 76.13 | Buy |
| Chaikin Money Flow: | 147064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.66 - 81.44) | Buy |
| Bollinger Bands (100): | (40.97 - 68.09) | Buy |
DAPP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.86 | Sell |
| 20-day SMA: | 18.28 | Sell |
| 50-day SMA: | 21.34 | Sell |
| 200-day SMA: | 16.53 | Buy |
| 8-day EMA: | 18.36 | Sell |
| 20-day EMA: | 18.9 | Sell |
| 50-day EMA: | 19.88 | Sell |
| 200-day EMA: | 17.85 | Sell |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.53 | Buy |
| 20-day SMA: | 72.88 | Buy |
| 50-day SMA: | 64.83 | Buy |
| 200-day SMA: | 42.54 | Buy |
| 8-day EMA: | 84.37 | Buy |
| 20-day EMA: | 75.93 | Buy |
| 50-day EMA: | 66.06 | Buy |
| 200-day EMA: | 46.89 | Buy |
VanEck Digital Transformation ETF Earnings Growth & DAPP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
VanEck Digital Transformation ETF Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||